SEARCH

Current Location: DOTmed News > Industry Headlines > This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

More Industry Headlines

Philips suspends CT and PET/CT production at Ohio facility Setback for customers and the company.

Varian's seven year patent dispute comes to an end Company will pay about $35 million.

FDA OKs GE's new CT scanner Ideal for challenging cases.

MRI technique can help treat concussion patients Measures white brain matter damage.

Special report: Contrast media One size does not fit all.

What's the big-picture impact of HIT on health care? Q&A with thought leader Bipin Thomas.

ABT's compact biomarker generator comes to Russia Ideal for the growing Russian market.

ClearMRI gets FDA clearance for MRI adaptor New option to extend the life of MRI systems.

Sebelius steps down from HHS post Sylvia Mathews Burwell to succeed Sebelius.

Physician payment data now available CMS releases records and AMA pushes back.

Da Vinci Si system (Credit: Intuitive)

Intuitive gets FDA OK for robot accessory

by Brendon Nafziger , DOTmed News Associate Editor
Intuitive Surgical Inc. said Monday it received Food and Drug Administration clearance for an accessory that lets the da Vinci surgical robot perform gallbladder surgery with a single incision. Analysts say this could one day help make the robot more attractive in the general surgery space.

The Single-Site Instrumentation kit includes a set of three instrument types, which are compatible with the robot, and are indicated for cholecystectomy, or the removal of the gallbladder. The kit works with the company's da Vinci Si systems.

Story Continues Below Advertisement

Cios Alpha - a new generation of Mobile C-arm Technology

With Cios Alpha Siemens brings to life a vision of a mobile C-arm that optimizes your surgical team's confidence, efficiency and operational workflow



The kit is one of three products Intuitive has in the works to broaden the appeal of its platform to general surgery, according to Rick Wise, with health care investment bank Leerink Swann. The other two, which haven't been cleared, are a surgical stapler and vessel sealer.

Roll-out of the device began in Europe several quarters ago, according to Wise, but was limited to under two dozen centers. Intuitive expects a "controlled" launch in the United States.

Wise said this was, for now, an early-stage technology.

"Single-incision surgery in general is in its early stages of adoption and its usage to date has been relatively limited," he said in a note to investors Tuesday.

In the release, Intuitive's CEO Gary Guthart said they would likely file future submissions with the FDA to expand the indications for the product.

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED